SCHEMBL31428466

SCHEMBL31428466

CC(=O)N1C(=Cc2ccc(OCC(=O)N3CCOCC3)c(-c3ccccc3)c2)C(=O)c2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.46
▸ MAPT P10636 5/20 0.46
▸ SMN1; SMN2 Q16637 4/20 0.46
▸ HTT P42858 3/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ KDM4E B2RXH2 4/20 0.46
▸ HPGD P15428 3/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ FKBP1A P62942 1/20 0.42
▸ GAA P10253 4/20 0.42
▸ KMT2A Q03164 6/20 0.42
▸ LMNA P02545 2/20 0.42
▸ MITF O75030 1/20 0.42
▸ CACNA1B Q00975 1/20 0.42
▸ APBA1 Q02410 1/20 0.42
▸ TSHR P16473 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ PARP1 P09874 1/20 0.41
▸ MEN1 O00255 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31428724 0.91 FKBP1A (0.53) ALDH1A1MAPTSMN1; SMN2HTTMAPK1
SCHEMBL30163514 0.90 ALDH1A1 (0.60) ALDH1A1MAPTSMN1; SMN2HTTMAPK1
SCHEMBL31428606 0.87 ALDH1A1 (0.47) ALDH1A1MAPTSMN1; SMN2HTTMAPK1
SCHEMBL31428687 0.83 FKBP1A (0.47) ALDH1A1MAPTSMN1; SMN2HTTMAPK1
SCHEMBL31428829 0.82 KDM4E (0.58) ALDH1A1MAPTSMN1; SMN2HTTMAPK1
SCHEMBL31428607 0.81 FKBP1A (0.47) ALDH1A1MAPTSMN1; SMN2HTTMAPK1
SCHEMBL30163501 0.81 ALDH1A1 (0.58) ALDH1A1MAPTSMN1; SMN2HTTMAPK1
SCHEMBL31428935 0.79 ALDH1A1 (0.58) ALDH1A1MAPTSMN1; SMN2HTTMAPK1
SCHEMBL31428414 0.79 ALDH1A1 (0.58) ALDH1A1MAPTSMN1; SMN2HTTMAPK1
SCHEMBL30163531 0.79 ALDH1A1 (0.62) ALDH1A1MAPTSMN1; SMN2HTTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) 2025-03-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND BRAF, RAF1, NRAS ALDH1A1 2352/4885MAPT 4513/4885SMN1; SMN2 4832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback